Cargando…
Paclitaxel attenuates renal interstitial fibroblast activation and interstitial fibrosis by inhibiting STAT3 signaling
Recent studies have demonstrated that paclitaxel might inhibit renal fibrosis. However, the underlying molecular mechanism remains unclear. In this study, we hypothesized that low-dose paclitaxel may block the STAT3 (signal transducer and activator of transcription 3) signaling to attenuate fibrosis...
Autores principales: | Zhang, Lei, Xu, Xuan, Yang, Ruhao, Chen, Jingwen, Wang, Shixuan, Yang, Junqin, Xiang, Xudong, He, Zhibiao, Zhao, Yu, Dong, Zheng, Zhang, Dongshan |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove Medical Press
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4404961/ https://www.ncbi.nlm.nih.gov/pubmed/25931810 http://dx.doi.org/10.2147/DDDT.S81390 |
Ejemplares similares
-
Paclitaxel: new uses for an old drug
por: Zhang, Dongshan, et al.
Publicado: (2014) -
p53 induces miR199a-3p to suppress SOCS7 for STAT3 activation and renal fibrosis in UUO
por: Yang, Ruhao, et al.
Publicado: (2017) -
Effect of Shenkang on renal fibrosis and activation of renal interstitial fibroblasts through the JAK2/STAT3 pathway
por: Qin, Tianyu, et al.
Publicado: (2021) -
Pomolic Acid Ameliorates Fibroblast Activation and Renal Interstitial Fibrosis through Inhibition of SMAD-STAT Signaling Pathways
por: Park, Ji-Hyun, et al.
Publicado: (2018) -
Src inhibition blocks renal interstitial fibroblast activation and ameliorates renal fibrosis
por: Yan, Yanli, et al.
Publicado: (2016)